On Tuesday, Macrogenics Inc (NASDAQ: MGNX) opened higher 4.13% from the last session, before settling in for the closing price of $1.21. Price fluctuations for MGNX have ranged from $0.99 to $5.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.47%. Company’s average yearly earnings per share was noted -71.96% at the time writing. With a float of $57.94 million, this company’s outstanding shares have now reached $63.09 million.
Let’s determine the extent of company efficiency that accounts for 341 employees. In terms of profitability, gross margin is 89.78%, operating margin of -65.25%, and the pretax margin is -36.0%.
Macrogenics Inc (MGNX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Macrogenics Inc is 8.16%, while institutional ownership is 80.39%. The most recent insider transaction that took place on Feb 15 ’25, was worth 1,083. In this transaction VP, Controller & Treasurer of this company sold 423 shares at a rate of $2.56, taking the stock ownership to the 9,532 shares.
Macrogenics Inc (MGNX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -71.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -25.45% during the next five years compared to 19.47% growth over the previous five years of trading.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Check out the current performance indicators for Macrogenics Inc (MGNX). In the past quarter, the stock posted a quick ratio of 3.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Looking closely at Macrogenics Inc (NASDAQ: MGNX), its last 5-days average volume was 2.57 million, which is a jump from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 12.69%.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 13.43%, which indicates a significant increase from 9.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.09% in the past 14 days, which was lower than the 94.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5110, while its 200-day Moving Average is $2.6056. However, in the short run, Macrogenics Inc’s stock first resistance to watch stands at $1.3267. Second resistance stands at $1.3933. The third major resistance level sits at $1.4617. If the price goes on to break the first support level at $1.1917, it is likely to go to the next support level at $1.1233. Now, if the price goes above the second support level, the third support stands at $1.0567.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
There are currently 63,090K shares outstanding in the company with a market cap of 79.49 million. Presently, the company’s annual sales total 149,960 K according to its annual income of -66,970 K. Last quarter, the company’s sales amounted to 13,190 K and its income totaled -41,040 K.
